Aerie Pharmaceuticals. Inc. (NASDAQ: AERI) is a publicly traded clinical stage pharmaceutical company focusing on the discovery of innovative treatments for glaucoma and other eye ailments. Its leading product candidates, Rhopressa™ and Roclatan™, are believed to be effective for most glaucoma patients, based on clinical trials results, and are currently in different stages of development […]

Recently disclosed developments to the OTCQX Best Market platform are likely to reduce the pain of going and being public for both domestic and foreign companies. In a note to clients, Jason Paltrowitz, Executive VP of Corporate Services at OTC Markets Group, outlined the enhancements, which include access by companies to globally recognized quantitative research […]

Before the opening bell, Singlepoint, Inc. (OTC: SING) gave prospective shareholders some additional insight into its plan to become one of the cannabis industry’s first merchant processors through its SingleSeed subsidiary. The update comes on the eve of a landmark Election Day during which five states will vote on ballot initiatives to legalize cannabis for […]

For a late-stage rare diseases focused boipharma innovator like Soligenix (OTCQB: SNGX), with up to $58 million of support for its Vaccines/BioDefense segment coming directly from NIAID contract funding (National Institute of Allergy and Infectious Diseases, a division of the NIH), recent news about the success of its BioTherapeutics segment is propitiously timed, amid the […]

Before the opening bell, Singlepoint, Inc. (OTC: SING) was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” The show includes informative interviews with company CEOs, offering prospective investors insight into their operations and outlooks for […]

At this year’s SuperZoo, The National Show for Pet Retailers that ran from July 31 – August 4 in Las Vegas, innovative pet care outfit OurPet’s Company (OTCQX: OPCO) launched its new OurPets® Switchgrass Natural Cat Litter™ with Biochar (http://dtn.fm/eI5Py). The timing was opportune. It seems there is growing awareness of biochar’s benefits. In a […]

Proposed amendments to the listing rules for the OTCQX Best Market are likely to benefit international companies. The rules, which will become effective from January 1, 2017, should make it easier for Canadian and other foreign companies to establish a secondary market in their shares for U.S. investors. For historical reasons, an OTC listing had […]

The marijuana industry is growing at a fast and steady pace, being set to reach $6.7 billion by the end of the year and approximately $20.6 billion by 2020 – making it one of the fastest growing sectors in the United States economy. The figures could go even higher as demand continues to grow and […]

The future of OurPet’s Company (http://dtn.fm/1Ypil) (OTCQX: OPCO), a producer of innovative pet related products, is looking bright thanks to the growth of the pets industry since 2014. Since its foundation in 1995, OurPet’s Company has been dedicated to providing nutritional, medical, physical, and emotional stimulation and value to pets across the U.S. But, the […]

Before the opening bell, Singlepoint, Inc. (OTC: SING) announced plans to awaken its SingleSeed subsidiary from a quiet period in an effort to capitalize on rising demand and an evolving legislative environment surrounding the cannabis market in the United States. With politicians on both sides of the aisle working toward a resolution to the current […]